Science Update: Biomarker for Niemann-Pick type C may be useful for diagnosing other class of rare disorders, NIH study suggests
Por um escritor misterioso
Descrição
A biomarker used to detect a rare neurodegenerative disorder of cholesterol metabolism, Niemann-Pick disease type C1 (NPC1), may also be useful for diagnosing another class of rare diseases known as congenital disorders of glycosylation (CDG), suggests a study by researchers at the National Institutes of Health.
Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine
Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study, Orphanet Journal of Rare Diseases
Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study, Orphanet Journal of Rare Diseases
Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial - The Lancet
Experimental treatment for Niemann-Pick disease type C1 appears safe, effective
IJMS, Free Full-Text
Niemann Pick Disease - an overview
Frontiers Inborn Errors of Metabolism Associated With Autism Spectrum Disorders: Approaches to Intervention
Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1, Biomarker Research
NIH teams with industry to develop treatments for Niemann-Pick Type C disease.
de
por adulto (o preço varia de acordo com o tamanho do grupo)